Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Yang

Epigenomics

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Epigenomics|December 6, 2013
PRC2 dysfunction through multiple mechanisms in myeloid malignanciesFan Yang
Epigenomics|December 6, 2013
H3K27me3 inhibitor: a potential new therapy for cytogenetically normal refractory cytopenia with multilineage dysplasiaFan Yang
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Epigenomics|December 6, 2013
PRC2 dysfunction through multiple mechanisms in myeloid malignanciesFan Yang
Epigenomics|December 6, 2013
H3K27me3 inhibitor: a potential new therapy for cytogenetically normal refractory cytopenia with multilineage dysplasiaFan Yang
Pageof 1